The cellular and molecular processes that control vascular injury responses after
percutaneous coronary intervention involve a complex interplay among vascular cells and …

It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective
percutaneous coronary intervention. However, the use of drug-eluting stent in patients with …

Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Diabetes mellitus (DM) has reached epidemic proportions worldwide, and its prevalence is
rising. 1, 2 The implications of a diagnosis of DM are as severe as a diagnosis of coronary …

Dual antiplatelet therapy with aspirin and a thienopyridine has been shown to reduce
cardiac events after coronary stenting. However, many patients and healthcare providers …

Background Recent reports have indicated that there may be an increased risk of late stent
thrombosis with the use of drug-eluting stents, as compared with bare-metal stents. Methods …

It is essential that the medical profession play a significant role in critically evaluating the use
of diagnostic procedures and therapies as they are introduced and tested in the detection …

Cardiovascular disease, particularly coronary artery dis-ease resulting from accelerated
atherosclerosis, is the leading cause of morbidity and mortality in patients with diabetes …